BRPA Big Rock Partners Acquisition Corp. Stock Quote

BRPA [NASD]

Index	-	P/E	-	EPS (ttm)	-0.17	Insider Own	71.78%	Shs Outstand	2.69M	Perf Week	-0.56%
Market Cap	77.09M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.76M	Perf Month	18.96%
Income	-0.40M	PEG	-	EPS next Q	-	Inst Own	4.20%	Short Float	4.77%	Perf Quarter	-21.47%
Sales	-	P/S	-	EPS this Y	-297.80%	Inst Trans	-70.16%	Short Ratio	0.84	Perf Half Y	202.45%
Book/sh	1.03	P/B	31.18	EPS next Y	-	ROA	-7.10%	Target Price	-	Perf Year	204.74%
Cash/sh	0.00	P/C	-	EPS next 5Y	-	ROE	-13.00%	52W Range	10.50 - 76.99	Perf YTD	31.64%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-58.28%	Beta	-0.05
Dividend %	-	Quick Ratio	0.10	Sales past 5Y	-	Gross Margin	-	52W Low	205.90%	ATR	4.46
Employees	2	Current Ratio	0.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	47.44	Volatility	14.74% 15.39%
Optionable	No	Debt/Eq	0.96	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.86	Prev Close	29.41
Shortable	No	LT Debt/Eq	0.96	Earnings	-	Payout	-	Avg Volume	43.24K	Price	32.12
Recom	-	SMA20	-6.78%	SMA50	-6.32%	SMA200	53.10%	Volume	37,180	Change	9.21%

Apr-19-21 03:57PM	NeuroRx Responds to Issues Raised by Relief Therapeutics Regarding ZYESAMI development PR Newswire -14.15%
Apr-07-21 06:35PM	Big Rock Partners Acquisition Corp. Clarifies Procedure for Stockholder Conversions and Urges Stockholders To Vote "For" Extension Amendment Proposal ACCESSWIRE -11.52%
Apr-06-21 01:01AM	NeuroRx Announces Zyesami (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir PR Newswire
Mar-29-21 07:52AM	/C O R R E C T I O N -- NeuroRx/ PR Newswire +12.51%
Mar-26-21 09:35AM	NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI for the Treatment of COVID-19 Respiratory Failure PR Newswire +36.33%
Mar-15-21 07:15AM	Neurorx, Inc. and Big Rock Partners Acquisition Corp. Announce Committed $10 Million Pipe to Support Proposed Business Combination ACCESSWIRE +8.33%
Mar-12-21 03:10PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, BRPA, and KTYB Shareholders About Its Ongoing Investigations PR Newswire
Mar-09-21 10:19AM	NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration PR Newswire
Mar-05-21 06:45PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations PR Newswire -5.00%
Feb-26-21 02:40PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations PR Newswire
Feb-23-21 01:10PM	NeuroRx Announces that ZYESAMI (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint PR Newswire +20.94%
Feb-19-21 04:15PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds GIX, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations PR Newswire +7.59%
Feb-12-21 12:16PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, JWS, BRPA and KTYB Shareholders About Its Ongoing Investigations PR Newswire -5.76%
Feb-09-21 08:13AM	NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19 PR Newswire -33.58%
07:30AM	NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19 PR Newswire
Feb-07-21 06:53PM	Lifshitz Law Firm, P.C. Announces Investigation of BRPA, CGRO, GXGX, HEC, FSRV, LCY, STPK, TPGY and VSPR PR Newswire
Feb-05-21 02:34PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, JWS, and BRPA Shareholders About Its Ongoing Investigations PR Newswire
Jan-29-21 05:46PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds JWS, BRPA, and UROV Shareholders About Its Ongoing Investigations PR Newswire +8.78%
Jan-22-21 03:45PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, JWS, BRPA, and ZAGG Shareholders About Its Ongoing Investigations PR Newswire -9.09%
Jan-14-21 05:19PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds STPK, FIII, JWS and BRPA Shareholders About Its Ongoing Investigations PR Newswire
Jan-11-21 01:00AM	NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI (RLF-100: aviptadil) in the I-SPY COVID-19 Trial PR Newswire
Jan-07-21 04:06PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds FIII, JWS, BRPA, and CGIX Shareholders About Its Ongoing Investigations PR Newswire +7.70%
Dec-30-20 09:00PM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Big Rock Partners Acquisition Corp. - BRPA PR Newswire -15.08%
01:00AM	NeuroRx and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100 for Critical COVID-19 with Respiratory Failure PR Newswire
Dec-23-20 06:13PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Big Rock Partners Acquisition Corp. Merger GlobeNewswire -21.40%
11:47AM	Top SPAC Merger News This Week: Porch.com, Butterfly Network, Ouster and More Spicy SPACs InvestorPlace
Dec-22-20 07:11PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, BRPA, and TPGY Shareholders About Its Ongoing Investigations PR Newswire +55.93%
Dec-15-20 06:02PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Big Rock Partners Acquisition Corp. PR Newswire -7.24%
Dec-14-20 08:15AM	Big Rock Partners Acquisition Corp. Announces Merger with NeuroRx, Inc. ACCESSWIRE +29.36%
Jun-12-20 11:19AM	Hedge Funds Are Dumping Big Rock Partners Acquisition Corp. (BRPA) Insider Monkey
Dec-17-19 04:08PM	Should You Buy Big Rock Partners Acquisition Corp. (BRPA)? Insider Monkey

Big Rock Partners Acquisition Corp. does not have significant operations. It intends to enter in to a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities on identifying a prospective target business. The company was founded in 2017 and is based in Delray Beach, Florida.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience